• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Big Data

Abbott integrates Libre CGM data into Epic EHR workflows

April 29, 2025 By Sean Whooley

This is an Abbott marketing image showing its new Libre app running on a smartphone with a Freestyle Libre sensor leaning against it.

Abbott (NYSE:ABT) announced today that it entered a first-of-its-kind agreement to integrate data from its Libre systems into Epic EHR systems. The partnership enables the integration of data from the Libre continuous glucose monitor (CGM) systems directly into Epic EHR in the U.S. Through this collaboration, the companies aim to improve workflow efficiency for providers […]

Filed Under: Big Data, Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Technology Tagged With: abbott, Epic

Tidepool achieves new certification for open-source quality management system

April 18, 2025 By Sean Whooley

Tidepool - updated logo

Tidepool announced today that it secured a new certification for its open-source quality management system, known as qmsOS. Palo Alto, California-based Tidepool, a non-profit diabetes data management group, develops open-source technology for the diabetes community. That includes the FDA-cleared Tidepool Loop, a “do-it-yourself” (DIY) automated insulin delivery (AID) system. Recent collaborations include integrations with Abbott and Sequel […]

Filed Under: Big Data, Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Regulatory/Compliance, Technology Tagged With: tidepool

Satio, Nanowear collab to bring AI-powered biomarkers to drug delivery

April 14, 2025 By Sean Whooley

Satio intradermal drug delivery system screenshot

Satio and Nanowear today announced that they partnered to advance patient-friendly, home-based diagnostic and therapeutic care. The collaboration aims to integrate Nanowear’s at-home AI-based nanotechnology biomarker diagnostic platform with Satio’s at-home blood draw diagnostics and drug delivery systems/patches. This would combine time-synchronous, in vivo and in vitro diagnostics for precision therapeutics and individualized AI-based risk […]

Filed Under: Big Data, Business/Financial News, Diagnostics, Drug-Device Combinations, Featured, Patient Monitoring, Technology Tagged With: Nanowear, Satio

Nanowear enters CGM licensing, data partnership with Dexcom

March 25, 2025 By Sean Whooley

Dexcom G7 Wearable Top (1)

Nanowear announced today that it entered into a partnership with Dexcom to ingest glucose data from its latest continuous glucose monitors (CGMs). The partnership will see Nanowear’s SimpleSense nanotechnology-enabled wearable, mobile and software diagnostics platform take data from the Dexcom G7 CGM, combining continuous glucose readings, blood pressure, ECGs, lung volume, respiration and hemodynamics. This […]

Filed Under: Big Data, Business/Financial News, Diabetes, Diagnostics, Featured, Patient Monitoring, Technology Tagged With: Dexcom, Nanowear

Glooko, Innovation Zed partner on digital companion apps for injection therapy management

February 6, 2025 By Sean Whooley

Glooko Innovation Zed

Glooko and Innovation Zed today announced a strategic partnership to develop and deploy digital companion apps for injectable therapies. Palo Alto, California-based Glooko’s current platforms enable patients to share diabetes data with healthcare providers. That includes blood glucose readings, insulin doses, food and carbs, exercise activity, blood pressure and weight. Ireland-based Innovation Zed develops insulin […]

Filed Under: Big Data, Business/Financial News, Drug-Device Combinations, Featured, Patient Monitoring, Technology Tagged With: glooko, Innovation Zed

Glooko announces CEO transition with $100M financing

October 10, 2024 By Sean Whooley

Mike Alvarez Glooko CEO (1)

Glooko announced today that it secured $100 million in a financing round and appointed Mike Alvarez as its new CEO. Russ Johannesson said on LinkedIn that he stepped down from the CEO post at Glooko. He held the corner office for six-and-a-half years as Alvarez now takes over. Alvarez brings more than two decades of […]

Filed Under: Big Data, Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Funding Roundup, Patient Monitoring, Personnel, Technology Tagged With: glooko, Personnel Moves

FDA clears new infusion pump and software from ICU Medical

August 29, 2023 By Sean Whooley

ICU Medical Plum Duo infusion pump and LifeShield infusion safety software

ICU Medical (Nasdaq:ICUI) announced today that the FDA granted 510(k) clearance to its Plum Duo infusion pump with LifeShield infusion safety software. The San Clemente, California-based company plans to make the pump and software available to U.S. customers in early 2024. Plum Duo, the latest addition to the ICU Medical infusion device portfolio, builds on […]

Filed Under: Big Data, Drug-Device Combinations, Featured, Food & Drug Administration (FDA), Hospital Care, Regulatory/Compliance, Technology Tagged With: ICU Medical

Glooko picks up security certification for diabetes patient management platform

February 6, 2023 By Sean Whooley

Glooko Logo

Glooko announced today that it received ISO 27001 certification for its data management and remote patient monitoring platforms. Palo Alto, California-based Glooko develops remote patient monitoring and chronic care management products. These include data management technologies for insulin delivery devices. ISO 27001, an international compliance framework, serves as the international security standard for protecting customer […]

Filed Under: Big Data, Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Technology Tagged With: glooko

Amalgam Rx, Novo Nordisk expand partnership on connected insulin delivery devices

December 19, 2022 By Sean Whooley

Amalgam Rx Novo Nordisk Dose Check partnership

Amalgam Rx announced today that it expanded its global agreement with Novo Nordisk over the commercialization of Dose Check. Wilmington, Delaware-based Amalgam Rx develops the Dose Check digital insulin initiation and titration app. It designed the app to help people with type 2 diabetes using basal insulin. The two companies partnered to incorporate and integrate […]

Filed Under: Auto-injectors, Big Data, Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Technology Tagged With: amalgamrx, Novo Nordisk

Data supports digital diabetes program from Carbon Health

November 30, 2022 By Sean Whooley

Carbon Health digital diabetes program

Carbon Health today announced patient data from its digital diabetes program, highlighting improved outcomes. San Francisco-based Carbon Health designed its endocrinologist-led platform to integrate with primary care. A certified team of diabetes educators supports the completely virtual platform. It offers accessibility to patients with no waiting or travel time involved. Carbon Health’s electronic health record […]

Filed Under: Big Data, Diabetes, Featured, Patient Monitoring, Technology Tagged With: Carbon Health

  • Page 1
  • Page 2
  • Page 3
  • Interim pages omitted …
  • Page 9
  • Go to Next Page »

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS